ArticleFrontiers in digital health2026
Explainable and interpretable models for predicting early-onset hypertension in the Tlalpan 2020 cohort.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early-onset hypertension results from complex interactions among demographic, lifestyle, metabolic, and psychosocial factors. While machine learning models can predict hypertension with relative accuracy, their lack of interpretability limits their clinical utility. Methods: Using a nested case-control design based on the Tlalpan 2020 prospective cohort, a 10-year study of clinically healthy adults in Mexico City, this study applies DSRegPSOP, a symbolic regression approach, to develop interpretable mathematical models. The dataset included demographic, clinical, biochemical, lifestyle, and sleep-related variables. We addressed class imbalance using oversampling and SMOTE-based strategies, and evaluated model performance with accuracy, sensitivity, specificity, F1-score, and AUC-ROC. Results: DSRegPSOP produced compact analytical expressions with predictive performance comparable to state-of-the-art machine learning algorithms while preserving interpretability. The resulting models reveal clinically meaningful predictors of early-onset hypertension. Conclusion: DSRegPSOP provides a transparent and interpretable model for hypertension risk assessment that shows promising potential to support early prevention strategies, pending external validation on independent cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.